Pristimerin as a Novel Hepatoprotective Agent Against Experimental Autoimmune Hepatitis
Pristimerin (Pris) is bioactive natural quinonoid triterpene that has anti-inflammatory and anti-cancer activities. Meanwhile, its effect against hepatitis needs to be elucidated. This investigation aimed to evaluate the ability of Pris to protect against autoimmune hepatitis (AIH). A mouse model of...
Saved in:
Main Authors: | Dina S. El-Agamy (Author), Ahmed A. Shaaban (Author), Hamdi H. Almaramhy (Author), Sarah Elkablawy (Author), Mohamed A. Elkablawy (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of glass fibers reinforced and non-reinforced composite resin on fracture behavior of severely destructed primary incisors and restored with post and core system
by: Rizk El Agamy
Published: (2024) -
Evaluation of hepatic toxicity in autoimmune hemolytic anemia (AIHA) and Evans syndrome patients: a single-center Egyptian study
by: Fatma Abozeid, et al.
Published: (2024) -
Hepatoprotective effect of dipeptidyl peptidase-4 inhibitor sitagliptin against carbon tetrachloride-induced liver fibrosis in mice
by: Ahmed A.N Ahmed, et al.
Published: (2021) -
Measuring the barriers against seeking consultation for urinary incontinence among Middle Eastern women
by: Shaaban Omar M, et al.
Published: (2010) -
Corrigendum: Mitigation of acetaminophen-induced liver toxicity by the novel phosphatidylinositol 3-kinase inhibitor alpelisib
by: Mohamed E. Shaker, et al.
Published: (2023)